Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.97 USD | -1.02% | -3.00% | -11.01% |
Financials (USD)
Sales 2024 * | 12.22M | Sales 2025 * | 5.87M | Capitalization | 183M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -32M | EV / Sales 2024 * | 15 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 31.2 x |
P/E ratio 2024 * |
-7.46
x | P/E ratio 2025 * |
-5.64
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.56% |
Latest transcript on Lineage Cell Therapeutics, Inc.
1 day | -1.02% | ||
1 week | -3.00% | ||
Current month | -3.00% | ||
1 month | -23.02% | ||
3 months | -14.16% | ||
6 months | -9.35% | ||
Current year | -11.01% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Deborah Andrews
BRD | Director/Board Member | 66 | 14-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.97 | -1.02% | 874,721 |
24-06-06 | 0.98 | +0.48% | 661,243 |
24-06-05 | 0.9753 | +0.28% | 885,758 |
24-06-04 | 0.9726 | -4.65% | 1,117,377 |
24-06-03 | 1.02 | +2.00% | 1,001,449 |
Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.01% | 183M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- LCTX Stock